Get the Stockscreener App
0.7147
0.29%
0.0021
Pre-market:
.72
0.0053
+0.74%
Inmed Pharmaceuticals Inc Stock (INM) Forecast
The Inmed Pharmaceuticals Inc (INM) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $31.32, representing a +4,282% increase from the current price of $0.7147. The highest analyst price target is $32.58, and the lowest is $30.05.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month INM Price Target
Average 25.68
(+3,492% Upside)
Is Inmed Pharmaceuticals Inc (INM) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 46.02 | Neutral |
| STOCH(9,6) | 81.30 | Sell |
| STOCHRSI(14) | 99.76 | Sell |
| MACD(12,26) | -0.0427 | Buy |
| ADX(14) | 32.51 | Sell |
| William %R | -3.6552 | Sell |
| CCI(14) | 34.49 | Neutral |
Buy: 1
Sell: 4
Neutral: 2
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.6802
Buy
|
0.6941
Buy
|
| MA20 |
0.7156
Sell
|
0.7191
Sell
|
| MA50 |
0.8223
Sell
|
0.837
Sell
|
| MA100 |
1.0204
Sell
|
1.085
Sell
|
| MA200 |
1.6544
Sell
|
1.6015
Sell
|
Buy: 2
Sell: 8
Neutral: 0
Summary: Sell
According to our latest analysis, INM could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 12 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on INM, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 46.02 indicates that INM is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 81.3 indicates that INM is oversold. This means that INM price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 99.76 indicates that INM is oversold. This suggests that INM price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 32.51 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 34.49 indicates that INM is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term INM price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Inmed Pharmaceuticals Inc financial reports and earnings history, Inmed Pharmaceuticals Inc (INM) stock could reach $73.73 by 2030, $302.69 by 2040 and $253.86 by 2050. See the projected annual prices until 2050 of the Inmed Pharmaceuticals Inc stock below:
- Inmed Pharmaceuticals Inc (INM) is expected to reach an average price of $63.65 in 2035, with a high prediction of $68.10 and a low estimate of $63.70. This indicates an $8,806% rise from the last recorded price of $0.7147.
- Inmed Pharmaceuticals Inc (INM) stock is projected to chart a bullish course in 2040, with an average price target of $319.69, representing an $44,631% surge from its current level. The forecast ranges from a conservative $2.3479 to a sky-high $302.69.
- Our analysts predict Inmed Pharmaceuticals Inc (INM) to jump 43,870% by 2045, soaring from $315.84 to an average price of $314.25, potentially reaching $311.59. While $315.84 is the low estimate, the potential upside is significant.
- Inmed Pharmaceuticals Inc (INM) stock is expected to climb by 2050, reaching an average of $250.30, a $34,922% jump from its current level. However, a wide range of estimates exists, with high and low targets of $253.86 and $250.59, respectively, highlighting the market's uncertainty.
Inmed Pharmaceuticals Inc Stock (INM) Year by Year Forecast
Inmed Pharmaceuticals Inc Stock (INM) Price Forecast for 2026
The predicted value for Inmed Pharmaceuticals Inc (INM) in 2026 is set at an average of $28.83. Estimates vary from a peak of $32.58 to a trough of $25.08, indicating an +3,934% surge from the present price of $0.7147.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2026 | $29.88 | $30.05 | $32.58 | +4,081% |
| June, 2026 | $31.51 | $31.43 | $29.50 | +4,309% |
| July, 2026 | $31.87 | $32.01 | $32.31 | +4,360% |
| August, 2026 | $30.58 | $30.75 | $31.08 | +4,179% |
| September, 2026 | $29.73 | $29.78 | $30.42 | +4,060% |
| October, 2026 | $27.98 | $28.11 | $28.35 | +3,815% |
| November, 2026 | $26.93 | $26.94 | $27.18 | +3,668% |
| December, 2026 | $25.01 | $25.08 | $26.45 | +3,399% |
Inmed Pharmaceuticals Inc Stock (INM) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Inmed Pharmaceuticals Inc (INM) is $15.19, with a high forecast of $24.60 and a low forecast of $5.7847. This indicates an +2,026% increase from the last price of $0.7147.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $23.43 | $23.51 | $24.60 | +3,179% |
| February, 2027 | $21.84 | $22.11 | $23.08 | +2,955% |
| March, 2027 | $20.03 | $20.05 | $21.27 | +2,703% |
| April, 2027 | $18.75 | $18.77 | $19.63 | +2,523% |
| May, 2027 | $17.13 | $17.19 | $18.24 | +2,297% |
| June, 2027 | $15.39 | $15.40 | $16.75 | +2,053% |
| July, 2027 | $13.95 | $14.00 | $14.92 | +1,852% |
| August, 2027 | $12.52 | $12.57 | $13.52 | +1,652% |
| September, 2027 | $10.77 | $10.86 | $12.14 | +1,406% |
| October, 2027 | $9.235 | $9.283 | $10.29 | +1,192% |
| November, 2027 | $7.6568 | $7.7293 | $8.806 | +971.33% |
| December, 2027 | $5.7572 | $5.7847 | $7.263 | +705.55% |
Inmed Pharmaceuticals Inc Stock (INM) Price Forecast for 2028
In 2028, Inmed Pharmaceuticals Inc (INM) is projected to reach an average price of $36.38, with a high projection of $72.36 and a low estimate of $0.398. This indicates an +4,990% rise from the last price of $0.7147.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $4.1301 | $4.1581 | $5.3108 | +477.88% |
| February, 2028 | $2.6195 | $2.6515 | $3.6784 | +266.51% |
| March, 2028 | $0.7788 | $0.8089 | $2.139 | +8.97% |
| April, 2028 | $67.92 | $0.398 | $71.45 | +9,403% |
| May, 2028 | $72.28 | $77.64 | $72.36 | +10,014% |
| June, 2028 | $46.17 | $51.95 | $43.42 | +6,360% |
| July, 2028 | $42.81 | $41.34 | $21.04 | +5,890% |
| August, 2028 | $61.92 | $44.50 | $57.92 | +8,564% |
| September, 2028 | $69.56 | $58.11 | $67.56 | +9,633% |
| October, 2028 | $69.70 | $54.75 | $64.20 | +9,652% |
| November, 2028 | $62.81 | $65.64 | $61.56 | +8,688% |
| December, 2028 | $64.70 | $57.25 | $56.18 | +8,952% |
Inmed Pharmaceuticals Inc Stock (INM) Price Forecast for 2029
The 2029 price forecast for Inmed Pharmaceuticals Inc Stock (INM) is $73.90 on average, with a high prediction of $80.08 and a low estimate of $67.72. This represents an +10,241% increase from the previous price of $0.7147.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $75.31 | $68.09 | $65.06 | +10,437% |
| February, 2029 | $71.95 | $67.72 | $64.45 | +9,967% |
| March, 2029 | $78.58 | $75.17 | $76.83 | +10,896% |
| April, 2029 | $79.85 | $81.35 | $77.31 | +11,072% |
| May, 2029 | $66.58 | $71.01 | $78.42 | +9,216% |
| June, 2029 | $73.47 | $75.97 | $73.25 | +10,180% |
| July, 2029 | $77.11 | $77.70 | $75.39 | +10,689% |
| August, 2029 | $77.72 | $76.50 | $76.33 | +10,775% |
| September, 2029 | $82.24 | $79.42 | $79.12 | +11,407% |
| October, 2029 | $75.10 | $75.25 | $80.08 | +10,408% |
| November, 2029 | $70.36 | $72.61 | $72.19 | +9,745% |
| December, 2029 | $71.50 | $72.00 | $70.77 | +9,904% |
Inmed Pharmaceuticals Inc Stock (INM) Price Forecast for 2030
Inmed Pharmaceuticals Inc Stock (INM) is expected to reach an average price of $61.44 in 2030, with a high forecast of $73.73 and a low forecast of $49.16. This signifies an +8,497% surge from the last price of $0.7147.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $75.10 | $73.47 | $73.73 | +10,408% |
| February, 2030 | $74.22 | $74.06 | $73.70 | +10,285% |
| March, 2030 | $71.29 | $71.39 | $72.66 | +9,874% |
| April, 2030 | $66.51 | $70.01 | $72.12 | +9,206% |
| May, 2030 | $68.33 | $68.43 | $67.09 | +9,460% |
| June, 2030 | $68.03 | $68.10 | $67.96 | +9,418% |
| July, 2030 | $63.90 | $64.06 | $66.51 | +8,840% |
| August, 2030 | $61.51 | $62.30 | $63.16 | +8,506% |
| September, 2030 | $58.61 | $58.63 | $59.72 | +8,101% |
| October, 2030 | $55.20 | $55.21 | $57.74 | +7,623% |
| November, 2030 | $52.36 | $52.42 | $54.33 | +7,226% |
| December, 2030 | $49.05 | $49.16 | $50.75 | +6,763% |
1.06%
1.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):